Orange Book product · Brand (NDA)
NAMENDA
MEMANTINE HYDROCHLORIDE
At a glance
Apr 18, 2005
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 18, 2005
21 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
MEMANTINE HYDROCHLORIDE
Strength
2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 021627
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2010NAMENDA XRBrand (NDA)
NDA 022525 · ABBVIE
- 2003NAMENDABrand (NDA)
NDA 021487 · ABBVIE
- 2025MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 206310 · MACLEODS PHARMS LTD
- 2022MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213985 · VITRUVIAS
- 2022MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204389 · HETERO LABS LTD V
- 2021MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214651 · AUROBINDO PHARMA LTD
- 2021MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211100 · YICHANG HUMANWELL
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210587 · PURACAP LABS BLU
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210319 · MEDLEY PHARMS
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212947 · YILING
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205365 · ANI PHARMS
- 2020MEMANTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208173 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

